Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Passweg

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
Bone Marrow Transplantation|July 5, 2016
Cardiac autonomic functioning is impaired among allogeneic hematopoietic stem cell transplantation survivors: a controlled studyG Deuring, A Kiss, J P Halter, et al.
Transplantation Proceedings|April 26, 2005
Levels of anti-A/B antibodies after ABO-incompatible hematopoietic stem cell transplantationG Stussi, K Huggel, U Schanz, et al.
Bone Marrow Transplantation|November 21, 2012
Standard treatment of acquired SAA in adult patients 18-40 years old with an HLA-identical sibling donorM Aljurf, H Al-Zahrani, M T Van Lint, et al.
Disease Models & Mechanisms|April 7, 2026
Bone marrow microenvironment in aplastic anemia: insights from Nestin/CXCL12 immunohistochemistry and RNA-sequencingA Beerlage, C P Zinner, J R Passweg, et al.
Annals of Hematology|January 20, 1998
Myeloid leukemia and myelodysplastic syndrome relapsing as granulocytic sarcoma (chloroma) after allogeneic bone marrow transplantationA Szomor, J R Passweg, A Tichelli, et al.
Bone Marrow Transplantation|August 29, 1998
Double allogeneic peripheral stem cell transplants for patients at high risk of relapseJ R Passweg, T Hoffmann, A Tichelli, et al.
Bone Marrow Transplantation|April 6, 2004
High-dose chemotherapy using BEAM for tumor debulking without stem cell support followed by early allogeneic reduced intensity conditioning transplantation to induce a graft-versus-lymphoma effect in patients with high risk or refractory lymphomaA S Buser, D Heim, C Bucher, et al.
Annals of Hematology|August 3, 2015
Synergistic effect of sorafenib and cGvHD in patients with high-risk FLT3-ITD+AML allows long-term disease control after allogeneic transplantationA Tschan-Plessl, J P Halter, D Heim, et al.
Revue Medicale Suisse|July 12, 2008
[Acute leukemias]J R Passweg, Y Chalandon, T Matthes, et al.
Bone Marrow Transplantation|December 7, 2000
Increased stem cell dose, as obtained using currently available technology, may not be sufficient for engraftment of haploidentical stem cell transplantsJ R Passweg, T Kühne, M Gregor, et al.
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Bone Marrow Transplantation|July 5, 2016
Cardiac autonomic functioning is impaired among allogeneic hematopoietic stem cell transplantation survivors: a controlled studyG Deuring, A Kiss, J P Halter, et al.
Transplantation Proceedings|April 26, 2005
Levels of anti-A/B antibodies after ABO-incompatible hematopoietic stem cell transplantationG Stussi, K Huggel, U Schanz, et al.
Bone Marrow Transplantation|November 21, 2012
Standard treatment of acquired SAA in adult patients 18-40 years old with an HLA-identical sibling donorM Aljurf, H Al-Zahrani, M T Van Lint, et al.
Disease Models & Mechanisms|April 7, 2026
Bone marrow microenvironment in aplastic anemia: insights from Nestin/CXCL12 immunohistochemistry and RNA-sequencingA Beerlage, C P Zinner, J R Passweg, et al.
Annals of Hematology|January 20, 1998
Myeloid leukemia and myelodysplastic syndrome relapsing as granulocytic sarcoma (chloroma) after allogeneic bone marrow transplantationA Szomor, J R Passweg, A Tichelli, et al.
Bone Marrow Transplantation|August 29, 1998
Double allogeneic peripheral stem cell transplants for patients at high risk of relapseJ R Passweg, T Hoffmann, A Tichelli, et al.
Bone Marrow Transplantation|April 6, 2004
High-dose chemotherapy using BEAM for tumor debulking without stem cell support followed by early allogeneic reduced intensity conditioning transplantation to induce a graft-versus-lymphoma effect in patients with high risk or refractory lymphomaA S Buser, D Heim, C Bucher, et al.
Annals of Hematology|August 3, 2015
Synergistic effect of sorafenib and cGvHD in patients with high-risk FLT3-ITD+AML allows long-term disease control after allogeneic transplantationA Tschan-Plessl, J P Halter, D Heim, et al.
Revue Medicale Suisse|July 12, 2008
[Acute leukemias]J R Passweg, Y Chalandon, T Matthes, et al.
Bone Marrow Transplantation|December 7, 2000
Increased stem cell dose, as obtained using currently available technology, may not be sufficient for engraftment of haploidentical stem cell transplantsJ R Passweg, T Kühne, M Gregor, et al.
Pageof 8